Articles by February, 2026

According to FutureWise analysis the market for minimally invasive surgery devices in 2026 is US$ 37.31 billion, and is expected to reach US$ 62.15 billion by 2036 at a CAGR of 5.24%. The growth is driven by the rising adoption of minimally invasive procedures in various specialties like general surgery, orthopedics, cardiology, and gynecology, thanks to benefits such as reduced pain and faster recovery. Technological advancements in endoscopic instruments, robotic systems, and imaging, along with the demand for outpatient and cost-effective solutions, are also fueling market expansion. Minimally invasive surgery (MIS) devices have greatly transformed surgical practices by allowing complex procedures to be conducted through smaller incisions. This approach enhances precision and contributes to better patient outcomes. These devices aim to minimize surgical trauma while achieving, or even surpassing, the effectiveness of traditional open surgeries. By reducing tissue damage and blood ... Continue reading →

According to FutureWise analysis, the Mid-Revenue Cycle Management or Clinical Documentation Improvement market in 2026 is US$4.52 billion, and is expected to reach US$7.83 billion by 2036 at a CAGR of 5.65%.  The Mid-Revenue Cycle Management and Clinical Documentation Improvement (CDI) market is currently experiencing significant growth, largely due to an increased focus on accurate clinical documentation and the urgent need to reduce claim denials. Healthcare providers are investing heavily in CDI solutions to enhance coding accuracy and ensure that they receive the reimbursements they are entitled to. As the healthcare industry transitions towards value-based care models, the importance of comprehensive documentation practices becomes even more critical. North America is at the forefront of this trend, driven by stringent healthcare compliance regulations and the widespread implementation of electronic health records (EHRs), which are transforming the documentation landscape. ... Continue reading →

According to FutureWise analysis the market for minimally invasive surgical instruments in 2026 is US$ 29.48 billion, and is expected to reach US$ 67.51 billion by 2036 at a CAGR of 8.64%. Strong growth in the market is driven by the increasing adoption of laparoscopic and endoscopic procedures in hospitals and surgical centers, thanks to benefits like reduced surgical trauma and quicker recovery. Innovations in handheld instruments and energy-based devices, along with a rising demand for precision in complex procedures, are further propelling market expansion. Minimally invasive surgical instruments, such as electrosurgical systems, robot-assisted surgical systems, and various surgical equipment, play a crucial role in modern surgical practices. Minimally invasive surgery (MIS) is defined as surgical treatment performed through small incisions, rather than the larger incisions associated with traditional open surgery. This approach offers several benefits, including faster recovery ... Continue reading →

The fantasy sports industry has witnessed exponential growth over the past decade, driven by increased smartphone adoption, affordable internet access, and rising engagement with live sports. Platforms like Dream11 have successfully transformed passive sports viewers into active participants by combining strategy, real-time data, and competitive gameplay. This success has inspired startups and enterprises alike to explore the development of Dream11 clone apps as a gateway into the lucrative fantasy sports market. However, building a sustainable fantasy sports platform goes far beyond replicating an existing interface. It requires a well-defined business strategy, a robust technical foundation, and a deep understanding of user behavior. This blueprint outlines the essential elements required to develop a Dream11 clone app that is scalable, compliant, and positioned for long-term success. The Business Logic Behind a Dream11 Clone App A Dream11 clone app operates on a skill-based gaming ... Continue reading →

According to FutureWise analysis the market for Minimally Invasive Thoracic Surgery in 2026 is US$ 5.04 billion, and is expected to reach US$ 7.57 billion by 2036 at a CAGR of 4.15%. Market growth is fueled by the rising use of video-assisted and robotic-assisted thoracic procedures for lung cancer and other chest conditions. Advantages like smaller incisions, less postoperative pain, shorter hospital stays, and better clinical outcomes are leading to greater acceptance among surgeons and patients in advanced healthcare settings. Minimally Invasive Thoracic Surgery (MITS) has become a transformative approach for diagnosing and treating diseases affecting the chest, including conditions related to the lungs, esophagus, pleura, and mediastinum. Unlike traditional open thoracic surgery, which often requires large incisions and the spreading of ribs, minimally invasive techniques use small incisions, specialized instruments, and advanced visualization systems to access thoracic structures ... Continue reading →

According to FutureWise analysis, the middle ear implants market in 2026 is US$ 46.99 million and is expected to reach US$ 86.21 million by 2036 at a CAGR of 4.66%.  The middle ear implants market is experiencing significant growth, primarily driven by the increasing prevalence of hearing loss among older adults and greater awareness of advanced hearing solutions. These implants offer distinct advantages over traditional hearing aids, such as superior sound quality and reduced feedback issues, making them particularly beneficial for patients with conductive or mixed hearing loss. Advancements in implant design and surgical techniques are further improving patient outcomes and expanding the pool of individuals eligible for these devices. Currently, Europe holds a substantial share of the market, thanks to supportive reimbursement policies and a high adoption rate of innovative medical technologies. Additionally, the market is thriving due to rising ... Continue reading →

According to FutureWise analysis the market for minimally invasive vertebral compression fracture treatments in 2026 is US$ 1.60 billion, and is expected to reach US$ 3.02 billion by 2036 at a CAGR of 6.56%. Growth in this field is fueled by the rising cases of osteoporosis-related fractures, an aging population, and the popularity of minimally invasive procedures like vertebroplasty and kyphoplasty, which provide quick pain relief and shorter recovery times compared to traditional surgery. A minimally invasive vertebral compression fracture (VCF) occurs when the vertebral body, a key component of the spinal structure, collapses or disintegrates under pressure. This condition can lead to significant complications such as spinal deformity, loss of height, and severe, debilitating pain that substantially affects a person's quality of life. VCFs can be attributed to various factors, including osteoporosis, which weakens the bones, traumatic injuries, pathologic fractures caused by ... Continue reading →

According to FutureWise analysis, the Migraine Drugs Marketin 2026 is US$6.54 billion and is expected to reach US$19.27 billion by 2036 at a CAGR of 11.41%.   Migraine is a common neurological condition characterized by severe and recurring headaches. These headaches typically occur on one side of the head and can last anywhere from 4 hours to 3 days. In addition to the headache, other symptoms may include nausea, vomiting, increased sensitivity to light (photophobia), increased sensitivity to sound (phonophobia), and tingling or numbness in the extremities or legs. Effective migraine treatment often requires the use of intramuscular medications. These medicines can help prevent migraine attacks and reduce headache pain, as well as alleviate associated symptoms, such as sensitivity to light and sound. Prompt treatment is essential, as it allows patients to return to their normal activities quickly and minimizes the need for pain medications. It is important to note that ... Continue reading →

According to FutureWise analysis the market for Minocycline Hydrochloride is expected to register a CAGR of 3.32% from 2026-2036. Market growth is driven by the drug's broad-spectrum antibiotic properties and its use in treating acne, bacterial infections, and inflammatory conditions. Ongoing research into new applications and strong demand in hospital and outpatient settings also support steady expansion. Minocycline Hydrochloride is a semi-synthetic, broad-spectrum tetracycline antibiotic that is widely utilized for treating various bacterial infections. Its mechanism of action involves the inhibition of bacterial protein synthesis, which effectively prevents the growth and proliferation of susceptible microorganisms. The drug is notable for its high lipid solubility and strong tissue penetration, making it effective against both gram-positive and gram-negative bacteria. This makes minocycline hydrochloride a valuable option in clinical settings. Commonly prescribed conditions ... Continue reading →

According to FutureWise analysis, the migraine nasal spray market in 2026 is US$0.55 billion, and is expected to reach US$1.10 billion by 2036 at a CAGR of 7.18%.  The migraine nasal spray market is on an impressive upward trajectory, driven by the rising global prevalence of migraine disorders that affect about 15% of people worldwide. As more individuals seek fast-acting, non-invasive treatment options, nasal sprays have become increasingly appealing. They offer rapid relief by allowing medication to be absorbed quickly through the nasal mucosa, which is especially beneficial for those enduring severe migraine attacks accompanied by nausea. Innovative formulations like CGRP inhibitors and ditans in nasal spray form are not only enhancing treatment options but also boosting market adoption. North America leads the charge, thanks to heightened awareness of migraines, a well-established healthcare system, and strong insurance support for prescription treatments. Additionally, the ... Continue reading →